According to the public relations of Actover Pharmaceutical Group, Abdolhossein Houshmand, CEO of the MS Association of Iran, stated that after the call for papers for the congress, over 70 articles were submitted to the congress secretariat, with many accepted. He mentioned that in this congress, which was held in collaboration with the MS Association of Iran and the Neurology Department of Tabriz University of Medical Sciences with the theme ‘Utilizing the Latest Scientific Results in Early Diagnosis and Proper Treatment of MS,’ the latest scientific evidence in the field of timely diagnosis and effective treatment of MS and other inflammatory diseases of the brain and spinal cord were presented in both basic and advanced stages.

Actover Pharmaceutical Group products for MS treatment

Actover Pharmaceutical Group, which plays a significant role in supplying medications for MS patients with products such as Actovex, Actoferon, Tecra, Gylenid, and Actiramer, produced with the highest quality and the most advanced global standards, had a prominent presence at the exhibition accompanying this congress, while supporting the organization of the event.

Actovex (Interferon beta-1a)
Actovex is the brand name for the drug Interferon Beta-1a, produced by Actoverco Pharmaceutical Factory. Actovex (Interferon Beta-1a) regulates the body’s immune responses.
This medication, in the form of a pre-filled syringe containing 30 micrograms of Interferon Beta-1a, is used for the treatment of relapsing multiple sclerosis (MS). While Interferon Beta-1a does not cure MS, it helps to reduce the frequency of disease flare-ups.

Actoferon (Interferon beta-1b)

Actoferon is the brand name for the drug Interferon Beta-1b, produced by Actoverco Pharmaceutical Factory. This drug, in the form of a vial containing 300 micrograms of lyophilized powder, regulates the body’s immune responses.

Actiramer (Glatiramer acetate)

Actiramer is the brand name for the drug Glatiramer Acetate, produced by Actoverco Pharmaceutical Factory. Actiramer (Glatiramer Acetate) regulates the body’s immune responses.
This product comes as a pre-filled syringe containing 40 mg of Glatiramer Acetate.
Used for patients with relapsing multiple sclerosis (MS), Actiramer does not cure MS but helps reduce the frequency of disease flare-ups.

Gylenid (Fingolimod)
Gylenid (Fingolimod) is an immune system suppressant drug used to treat multiple sclerosis (MS).
This drug is available in the form of 0.5 mg capsules and is used in the treatment of relapsing multiple sclerosis.

Tecra (Dimethyl fumarate)

Tecra is an immune system modulator that includes Dimethyl Fumarate, a derivative of fumaric acid, used for treating multiple sclerosis (MS).
This drug comes in the form of enteric-coated capsules of 120 mg and 240 mg and is used in the treatment of relapsing multiple sclerosis.

Tecra and Gylenid medicines are products of Alborz Zagros Pharmaceutical Company, the only Iranian factory with the global OEB5 standard, the highest quality standard in Iran and the region. This factory, which is part of the Actover Group, has two equipped lines designed to produce drugs with hazardous raw materials (HAZARDOUS) for the treatment of various diseases, including MS, organ transplants, and more, in different pharmaceutical forms such as tablets and capsules. The factory was launched in 2021, and today, we can proudly observe the effectiveness and high quality of the products in treating patients across our country.

In addition to MS treatment drugs, Actover also produces two anticonvulsant medications, Eleppra and Lasca, to assist these patients.

Eleppra (Levetiracetam)
Eleppra is the brand name of a neurology drug called Levetiracetam, produced by Actoverco Pharmaceutical Company. It is available in tablet form with dosages of 250, 500, 750, and 1000 mg.
Levetiracetam, which belongs to the class of antiepileptic drugs, is prescribed for the treatment of epilepsy to reduce the frequency of seizures.

Lacsa (Lacosamide)

Lacsa is the brand name of a drug called Lacosamide, produced by Actoverco Pharmaceutical Company.
Lacosamide, which also belongs to the class of antiepileptic drugs, is used for the treatment of epilepsy to decrease the number of seizures.

Rituxiver (Rituximab)
Ritoxior is the brand name for Rituximab, a targeted cancer therapy drug produced by Actover Pharmaceutical Company. Rituximab is used in the treatment of various cancers, including non-Hodgkin lymphoma and chronic lymphocytic leukemia, by targeting specific cells in the immune system to slow or stop the growth of cancer cells.